what's glp 1 GLP-1 Agonists: A Comprehensive Overview What is GLP-1 and Its

These phenomena, coupled with the re-development of overweight or obesity and poor glycaemic control when not on therapy, might increase the long-term risk of complications

There is heterogeneity in data regarding insulin dose adjustments after initiating GLP-1 RA therapy

There is also a more subtle risk worth knowing: the Pasqua 2025 trial reported two cases of euglycemic ketosis without acidosis in semaglutide-treated participants

Overall, oral semaglutide compared favorably in terms of the efficacy endpoints examined

Tirzepatide induces ferroptosis in glioblastoma cell lines via the SOX2/SLC7A11 axis: a potential therapeutic strategy for glioma treatment

17,18 A post hoc analysis of LOOK AHEAD trial data found that participants who achieved at least a 10% body weight loss in the first year had a 21% lower rate of major adverse cardiac events